Home › Neuroblastoma › California › Mountain View
Neuroblastoma clinical trials in Mountain View, CA
5 studies for Neuroblastoma are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi away
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi away
SPEARHEAD-3 Pediatric Study
RecruitingPhase 1/2
- Stanford University, Palo Alto · 5 mi away
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi away
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RecruitingPhase 1
- Stanford University, Palo Alto · 5 mi away
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Philadelphia, PA9 studies
- Birmingham, AL8 studies
- Hartford, CT8 studies
- Aurora, CO8 studies
- Minneapolis, MN8 studies
- Miami, FL7 studies
Other studies in Mountain View
- Cancer (all types)41 studies
- Metastatic Cancer25 studies
- Breast Cancer24 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Lung Cancer17 studies
- Autism Spectrum Disorder17 studies
- Prostate Cancer15 studies
- Colorectal Cancer14 studies
- Heart Failure14 studies
- Acute Lymphoblastic Leukemia13 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.